Critical information to help you understand your diagnosis and treatment options
The pathologist's analysis of tumor tissue is an absolute critical starting point for an accurate diagnosis, in order to plan for the appropriate treatment protocol. Diagnosing soft tissue sarcomas can be challenging even with adequate biopsies or resection specimens.
Soft tissue sarcomas are rare cancers with more than 100 different subgroups and tremendous morphologic heterogeneity. Based on the fact that pathologic diagnosis dictates prognosis and treatment, patients suffering from this orphan disease should receive a second opinion from a soft tissue pathologist before a final treatment decision is made.
Takeaway message: Patients should be mandatorily treated in specialized centers by a multidisciplinary team in close cooperation with physicians interested in this orphan disease.
Molecular pathology is a vital piece of the sarcoma puzzle. Identifying the presence of proteins in a tumor sample and genomic sequencing along with other molecular analysis to pinpoint a sarcoma's unique characteristics / gene characterization/sequencing is part of the pathology process.
Genetic abnormalities that are known to drive sarcoma growth are also involved in molecular diagnostic tests.
"Knowing what drives a tumor is what allows for pinpointing the best treatment approach, but with LMS, the gene mutation burden is quite low."
Knowing what "drives" the tumor allows for pinpointing the best treatment approach. Staging the tumor - establishing its size, and possible spread based on the above, plus "differentiation" of the cancer cells, and the mitotic rate, including possible evidence of tumor "necrosis" - all contribute to the grading of the tumor.
In cancer, this describes how much or how little tumor tissue looks like the normal tissue it came from. Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.
Mitotic rate measures how fast melanoma cells are dividing and growing. It is a prognostic factor that can help predict outcomes and treatment options.
Necrotic tumors are masses with dead tissue inside, caused by insufficient blood flow to the tumor cells. A form of cell death that can affect cancer treatment and prognosis.
Dr. Brian Van Tine leads a discussion about the diagnostic workup of a new patient, the usefulness of imaging and genetic testing, and more in this informative video.
The stages of soft tissue sarcomas range from stages I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more.
Understanding staging and grading is crucial when interpreting your pathology report. Staging determines the extent of cancer spread, while grading assesses how aggressive the cancer cells appear.
For comprehensive information about how tumors are staged and graded, including the specifics for sarcoma classification, please visit our detailed guide:
Complete Staging & Grading Guide